Evidence for immune-mediated reduction of viral replication in Macaca nemestrina mucosally immunized with inactivated SHIV89.6 (Q43939295)

reason for preferred rank

28 November 2017

Evidence for immune-mediated reduction of viral replication in Macaca nemestrina mucosally immunized with inactivated SHIV89.6 (English)

1 reference

https://api.crossref.org/works/10.1016/S0042-6822(03)00027-8

26 December 2023

Evidence for immune-mediated reduction of viral replication in Macaca nemestrina mucosally immunized with inactivated SHIV(89.6) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706101

southern pig-tailed macaque

26 December 2023

main subject

0 references

0 references

8

David C Montefiori

1 reference

28 November 2017

1

Zandrea Ambrose

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706101

26 December 2023

author name string

Jannelle Thompson

2

1 reference

28 November 2017

Kay Larsen

3

1 reference

28 November 2017

Larene Kuller

4

1 reference

28 November 2017

Michael Agy

7

1 reference

28 November 2017

Shiu Lok Hu

9

1 reference

28 November 2017

Dennis L. Panicali

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706101

26 December 2023

John D. Clements

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706101

26 December 2023

Marnix L. Bosch

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706101

26 December 2023

language of work or name

English

0 references

publication date

1 March 2003

1 reference

28 November 2017

30 March 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12706101

full work available at URL

26 December 2023

https://api.elsevier.com/content/article/PII:S0042682203000278?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0042-6822(03)00027-8

https://api.elsevier.com/content/article/PII:S0042682203000278?httpAccept=text/plain

26 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0042-6822(03)00027-8

26 December 2023

1 reference

28 November 2017

308

1 reference

28 November 2017

178-190

1 reference

28 November 2017

1

1 reference

Evidence for early local viral replication and local production of antiviral immunity upon mucosal simian-human immunodeficiency virus SHIV(89.6) infection in Macaca nemestrina

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Persistent infection with SIVmac chimeric virus having tat, rev, vpu, env and nef of HIV type 1 in macaque monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Combined systemic and mucosal immunization with microsphere-encapsulated inactivated simian immunodeficiency virus elicits serum, vaginal, and tracheal antibody responses in female rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Protective immunity induced by live attenuated simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Mucosal antibody expression following rapid SIV(Mne) dissemination in intrarectally infected Macaca nemestrina

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV).

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Protection against vaginal SIV transmission with microencapsulated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Progesterone implants enhance SIV vaginal transmission and early virus load

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G)

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Heterologous neutralizing antibody induction in a simian-human immunodeficiency virus primate model: lack of original antigenic sin.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Initial characterization of viral sequences from a SHIV-inoculated pig-tailed macaque that developed AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Characterization of primary isolate-like variants of simian-human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900027-8

7 January 2021

Developments in preclinical AIDS vaccine efficacy models

8

1 reference

https://api.crossref.org/works/10.1016/S0042-6822(03)00027-8

The role of nonhuman primates in the development of an AIDS vaccine

26 December 2023

36

1 reference

https://api.crossref.org/works/10.1016/S0042-6822(03)00027-8

26 December 2023

Identifiers

1 reference

28 November 2017

1 reference